La Trobe
fimmu-12-620963.pdf (819.42 kB)

Platelets in Multiple Sclerosis: Early and Central Mediators of Inflammation and Neurodegeneration and Attractive Targets for Molecular Imaging and Site-Directed Therapy

Download (819.42 kB)
journal contribution
posted on 2021-04-20, 04:38 authored by Jacqueline OrianJacqueline Orian, Claretta D Souza, Pece Kocovski, G Krippner, Matthew HaleMatthew Hale, Xiaowei WangXiaowei Wang, Karlheinz PeterKarlheinz Peter
Platelets are clearly central to thrombosis and hemostasis. In addition, more recently, evidence has emerged for non-hemostatic roles of platelets including inflammatory and immune reactions/responses. Platelets express immunologically relevant ligands and receptors, demonstrate adhesive interactions with endothelial cells, monocytes and neutrophils, and toll-like receptor (TLR) mediated responses. These properties make platelets central to innate and adaptive immunity and potential candidate key mediators of autoimmune disorders. Multiple sclerosis (MS) is the most common chronic autoimmune central nervous system (CNS) disease. An association between platelets and MS was first indicated by the increased adhesion of platelets to endothelial cells. This was followed by reports identifying structural and functional changes of platelets, their chronic activation in the peripheral blood of MS patients, platelet presence in MS lesions and the more recent revelation that these structural and functional abnormalities are associated with all MS forms and stages. Investigations based on the murine experimental autoimmune encephalomyelitis (EAE) MS model first revealed a contribution to EAE pathogenesis by exacerbation of CNS inflammation and an early role for platelets in EAE development via platelet-neuron and platelet-astrocyte associations, through sialated gangliosides in lipid rafts. Our own studies refined and extended these findings by identifying the critical timing of platelet accumulation in pre-clinical EAE and establishing an initiating and central rather than merely exacerbating role for platelets in disease development. Furthermore, we demonstrated platelet-neuron associations in EAE, coincident with behavioral changes, but preceding the earliest detectable autoreactive T cell accumulation. In combination, these findings establish a new paradigm by asserting that platelets play a neurodegenerative as well as a neuroinflammatory role in MS and therefore, that these two pathological processes are causally linked. This review will discuss the implications of these findings for our understanding of MS, for future applications for imaging toward early detection of MS, and for novel strategies for platelet-targeted treatment of MS.


CD'S was supported by a La Trobe University Post-graduate Research scholarship and PK by an Australian Research Training scholarship. JO was funded by the La Trobe University Research Focus Area scheme (grant number: 2000004433) and the La Trobe Alumni, XW by a Future Leader Fellowship of the National Heart Foundation of Australia (NHF), and KP by a Leadership Level 3 Fellowship of the Australian National Health and Medical Research Council (NHMRC). The authors would like to thank the La Trobe Animal Research and Training Facility and La Trobe Institute for Molecular Science Bioimaging Platform.


Publication Date



Frontiers in Immunology



Article Number





Frontiers Media



Rights Statement

The Author reserves all moral rights over the deposited text and must be credited if any re-use occurs. Documents deposited in OPAL are the Open Access versions of outputs published elsewhere. Changes resulting from the publishing process may therefore not be reflected in this document. The final published version may be obtained via the publisher’s DOI. Please note that additional copyright and access restrictions may apply to the published version.